Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk
暂无分享,去创建一个
[1] B. Cheung,et al. Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008. , 2012, Annals of epidemiology.
[2] J. Moreno-Navarrete,et al. Type I iodothyronine 5′-deiodinase mRNA and activity is increased in adipose tissue of obese subjects , 2012, International Journal of Obesity.
[3] E. Ravussin,et al. Novel strategy for the use of leptin for obesity therapy , 2011, Expert opinion on biological therapy.
[4] Mary T. Brinkoetter,et al. Leptin in human physiology and pathophysiology. , 2011, American journal of physiology. Endocrinology and metabolism.
[5] M. Obregon,et al. Presence and regulation of D1 and D2 deiodinases in rat white adipose tissue. , 2011, Metabolism: clinical and experimental.
[6] M. Rudling,et al. Thyromimetics: a journey from bench to bed-side. , 2011, Pharmacology & therapeutics.
[7] J. Satoh,et al. Higher serum free triiodothyronine levels within the normal range are associated with metabolic syndrome components in type 2 diabetic subjects with euthyroidism. , 2011, The Tohoku journal of experimental medicine.
[8] H. Bays. Adiposopathy is "sick fat" a cardiovascular disease? , 2011, Journal of the American College of Cardiology.
[9] P. Schauer,et al. Reduced Cardiovascular Risk Following Bariatric Surgeries is Related to a Partial Recovery from “Adiposopathy” , 2011, Obesity surgery.
[10] M. Alemany. The defense of adipose tissue against excess substrate-induced hyperthrophia: immune system cell infiltration and arrested metabolic activity. , 2011, The Journal of clinical endocrinology and metabolism.
[11] A. Kosaki,et al. Type 2 iodothyronine deiodinase is expressed in human preadipocytes. , 2011, Thyroid : official journal of the American Thyroid Association.
[12] W. Teng,et al. The Correlation between Thyrotropin and Dyslipidemia in a Population-based Study , 2011, Journal of Korean medical science.
[13] Z. Kováčová,et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. , 2010, The Journal of clinical endocrinology and metabolism.
[14] Ricardo Lage,et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance , 2010, Nature Medicine.
[15] T. Dayspring,et al. Impact of triglycerides on lipid and lipoprotein biology in women. , 2010, Gender medicine.
[16] P. Ladenson,et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. , 2010, The New England journal of medicine.
[17] Thomas S. Scanlan,et al. Sobetirome: a case history of bench-to-clinic drug discovery and development , 2010, Heart Failure Reviews.
[18] H. Bays. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for ‘sick fat’ and metabolic disease , 2009, Expert review of cardiovascular therapy.
[19] Karen A Robinson,et al. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. , 2009, The Journal of clinical endocrinology and metabolism.
[20] M. Viora,et al. Leptin exerts an anti‐apoptotic effect on human dendritic cells via the PI3K‐Akt signaling pathway , 2009, FEBS letters.
[21] M. Rotondi,et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? , 2009, European journal of endocrinology.
[22] H. Rodbard,et al. Is adiposopathy (sick fat) an endocrine disease? , 2008, International journal of clinical practice.
[23] C. Apovian,et al. Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[24] M. Mansour,et al. Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[25] C. Nathan. Epidemic Inflammation: Pondering Obesity , 2008, Molecular medicine.
[26] D. Bessesen. Update on obesity. , 2008, The Journal of clinical endocrinology and metabolism.
[27] L. Heilbronn,et al. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. , 2008, Current pharmaceutical design.
[28] M. Obregon. Thyroid hormone and adipocyte differentiation. , 2008, Thyroid : official journal of the American Thyroid Association.
[29] K. Clément,et al. Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[30] B. Chand,et al. Influence of obesity and surgical weight loss on thyroid hormone levels. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[31] G. Ness,et al. Activation of the hepatic LDL receptor promoter by thyroid hormone. , 2007, Biochimica et biophysica acta.
[32] Bohan Wang,et al. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes , 2007, Pflügers Archiv - European Journal of Physiology.
[33] L. Vatten,et al. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. , 2007, The Journal of clinical endocrinology and metabolism.
[34] T. Reinehr,et al. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. , 2006, The Journal of clinical endocrinology and metabolism.
[35] N. Abate,et al. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. , 2005, Future cardiology.
[36] H. Pijl,et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. , 2005, The Journal of clinical endocrinology and metabolism.
[37] F. Leonetti,et al. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women , 2005, Clinical endocrinology.
[38] X. Qiang,et al. The obesity pandemic: where have we been and where are we going? , 2004, Obesity research.
[39] K. Flegal,et al. Epidemiologic trends in overweight and obesity. , 2003, Endocrinology and metabolism clinics of North America.
[40] L. Orci,et al. Lipoapoptosis: its mechanism and its diseases. , 2002, Biochimica et biophysica acta.
[41] B. Howard,et al. Dyslipidemia of the metabolic syndrome , 2002, Current cardiology reports.
[42] S. O’Rahilly. Leptin: defining its role in humans by the clinical study of genetic disorders. , 2002, Nutrition reviews.
[43] S. Wang,et al. Serum leptin concentrations of patients with sequential thyroid function changes , 2002, Clinical endocrinology.
[44] E. Jéquier. Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.
[45] E. Ravussin,et al. Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus , 2002, Annals of the New York Academy of Sciences.
[46] L. Duntas. Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.
[47] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[48] D. Barbier. [Depression in the elderly. Clinical aspects]. , 2001, Presse medicale.
[49] L. Hoffer,et al. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. , 1997, The Journal of clinical endocrinology and metabolism.
[50] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[51] R. Krauss,et al. Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men. , 1994, Metabolism: clinical and experimental.
[52] E. Danforth. The role of thyroid hormones and insulin in the regulation of energy metabolism. , 1983, The American journal of clinical nutrition.
[53] E. Drenick,et al. Excessive mortality and causes of death in morbidly obese men. , 1980, JAMA.
[54] E. A. Sims,et al. Spontaneous and experimental human obesity: effects of diet and adipose cell size on lipolysis and lipogenesis. , 1977, Metabolism: clinical and experimental.
[55] R. Ness-Abramof,et al. A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice , 2012 .
[56] P. Eller,et al. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia. , 2011, Recent patents on cardiovascular drug discovery.
[57] G. Kaushik,et al. Subclinical hypothyroidism and its association with cardiovascular risk factors. , 2011, Clinical laboratory.
[58] H. Bays. "Sick fat," metabolic disease, and atherosclerosis. , 2009, The American journal of medicine.
[59] M. Wong,et al. Cellular Immunity Before and After Leptin Replacement Therapy , 2009, Journal of pediatric endocrinology & metabolism : JPEM.
[60] F. Casanueva,et al. TSH stimulates leptin secretion by a direct effect on adipocytes. , 2003, The Journal of endocrinology.
[61] L. Duntas,et al. Thyrotropin releasing hormone (TRH) immunoreactivity and thyroid function in obesity. , 1991, International journal of obesity.